Annual Operating Profit
-$24.97 M
-$4.77 M-23.59%
01 December 2023
Summary:
Actuate Therapeutics annual operaing income is currently -$24.97 million, with the most recent change of -$4.77 million (-23.59%) on 01 December 2023.ACTU Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$5.39 M
+$42.50 K+0.78%
01 September 2024
Summary:
Actuate Therapeutics quarterly operating income is currently -$5.39 million, with the most recent change of +$42.50 thousand (+0.78%) on 01 September 2024. Over the past year, it has increased by +$1.08 million (+16.72%).ACTU Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$26.22 M
+$1.08 M+3.97%
01 September 2024
Summary:
Actuate Therapeutics TTM operating income is currently -$26.22 million, with the most recent change of +$1.08 million (+3.97%) on 01 September 2024. Over the past year, it has dropped by -$8.86 million (-51.03%).ACTU TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACTU Operating Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -23.6% | +16.7% | -51.0% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
ACTU Operating Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | +23.6% | +1.8% | +394.8% |
Actuate Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$5.39 M(-0.8%) | -$26.22 M(-4.0%) |
June 2024 | - | -$5.44 M(-30.1%) | -$27.30 M(-0.5%) |
Mar 2024 | - | -$7.77 M(+2.1%) | -$27.45 M(+9.9%) |
Dec 2023 | -$24.97 M | -$7.62 M(+17.6%) | -$24.97 M(+43.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$6.48 M(+16.0%) | -$17.36 M(+59.5%) |
June 2023 | - | -$5.58 M(+5.4%) | -$10.88 M(+105.4%) |
Mar 2023 | - | -$5.30 M | -$5.30 M |
Dec 2022 | -$20.21 M | - | - |
FAQ
- What is Actuate Therapeutics annual operaing income?
- What is the all time high annual operating profit for Actuate Therapeutics?
- What is Actuate Therapeutics annual operating profit year-on-year change?
- What is Actuate Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Actuate Therapeutics?
- What is Actuate Therapeutics quarterly operating profit year-on-year change?
- What is Actuate Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Actuate Therapeutics?
- What is Actuate Therapeutics TTM operating profit year-on-year change?
What is Actuate Therapeutics annual operaing income?
The current annual operating profit of ACTU is -$24.97 M
What is the all time high annual operating profit for Actuate Therapeutics?
Actuate Therapeutics all-time high annual operaing income is -$20.21 M
What is Actuate Therapeutics annual operating profit year-on-year change?
Over the past year, ACTU annual operaing income has changed by -$4.77 M (-23.59%)
What is Actuate Therapeutics quarterly operating income?
The current quarterly operating profit of ACTU is -$5.39 M
What is the all time high quarterly operating profit for Actuate Therapeutics?
Actuate Therapeutics all-time high quarterly operating income is -$5.30 M
What is Actuate Therapeutics quarterly operating profit year-on-year change?
Over the past year, ACTU quarterly operating income has changed by +$1.08 M (+16.72%)
What is Actuate Therapeutics TTM operating income?
The current TTM operating profit of ACTU is -$26.22 M
What is the all time high TTM operating profit for Actuate Therapeutics?
Actuate Therapeutics all-time high TTM operating income is -$5.30 M
What is Actuate Therapeutics TTM operating profit year-on-year change?
Over the past year, ACTU TTM operating income has changed by -$8.86 M (-51.03%)